Information from drug companies and opinion leaders

Medicines not recommended for inclusion in the who essential medicines list: a retrospective observational study.

Frontiers in medicine·2025

WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2024

Uptake of orphan drugs in the WHO essential medicines lists.

Bulletin of the World Health Organization·2024

How to tailor recommendations on the treatment of multi-drug resistant Gram-negative infections at country level integrating antibiotic stewardship principles within the GRADE-ADOLOPMENT framework.

The Lancet. Infectious diseases·2023

Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern.

eLife·2022

[Harmonizing development, approval and access of drugs for rare diseases in Europe.]

Recenti progressi in medicina·2022

Simultaneous derivation, validation, and comparison of predictor hazard ratios for cardiovascular risk prediction equations in patients with diabetes from high versus non-high income countries: cohort study.

BMJ (Clinical research ed.)·2026

Advances in the diagnosis and management of skin and soft tissue infections.

BMJ (Clinical research ed.)·2026

Exploring high priority potentially inappropriate prescribing cascades in older adults: population level retrospective cohort study.

BMJ (Clinical research ed.)·2026

Cardiovascular Effects of Chronic GIPR and GLP-1R Agonism in Lean and Diet-Induced Obese Mice: Sex Differences and Dose-Dependent Remodeling.

American journal of physiology. Heart and circulatory physiology·2026

Method Development for Simultaneous Quantification of Anti-diabetic Drugs in Combined Solid Dosage Form: A Focus on Sulfonylureas, Biguanides, and Thiazolidinediones.

Current drug research reviews·2026

Specialty-based variation in glucagon-like Peptide-1 receptor agonist prescribing practices for adolescent obesity in Saudi Arabia.

Obesity pillars·2026

[The effects of methylprednisolone pulse therapy on glucose metabolism parameters in children with autoimmune and autoinflammatory diseases].

Problemy endokrinologii·2026

[Expert consensus on initial combination lipid-lowering therapy in patients with type 2 diabetes mellitus and hypertension (2026)].

Zhonghua nei ke za zhi·2026

Postbiotic Metabolites: Therapeutic Potential, Industrial Applications, Market Dynamics, and Regulatory Frameworks.

Probiotics and antimicrobial proteins·2026

Related Experiment Videos

Information from drug companies and opinion leaders

Related Concept Videos

Medicines not recommended for inclusion in the who essential medicines list: a retrospective observational study.

WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections.

Uptake of orphan drugs in the WHO essential medicines lists.

How to tailor recommendations on the treatment of multi-drug resistant Gram-negative infections at country level integrating antibiotic stewardship principles within the GRADE-ADOLOPMENT framework.

Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern.

[Harmonizing development, approval and access of drugs for rare diseases in Europe.]

Simultaneous derivation, validation, and comparison of predictor hazard ratios for cardiovascular risk prediction equations in patients with diabetes from high versus non-high income countries: cohort study.

Advances in the diagnosis and management of skin and soft tissue infections.

Exploring high priority potentially inappropriate prescribing cascades in older adults: population level retrospective cohort study.

Cardiovascular Effects of Chronic GIPR and GLP-1R Agonism in Lean and Diet-Induced Obese Mice: Sex Differences and Dose-Dependent Remodeling.

Method Development for Simultaneous Quantification of Anti-diabetic Drugs in Combined Solid Dosage Form: A Focus on Sulfonylureas, Biguanides, and Thiazolidinediones.

Specialty-based variation in glucagon-like Peptide-1 receptor agonist prescribing practices for adolescent obesity in Saudi Arabia.

[The effects of methylprednisolone pulse therapy on glucose metabolism parameters in children with autoimmune and autoinflammatory diseases].

[Expert consensus on initial combination lipid-lowering therapy in patients with type 2 diabetes mellitus and hypertension (2026)].

Postbiotic Metabolites: Therapeutic Potential, Industrial Applications, Market Dynamics, and Regulatory Frameworks.

Related Experiment Videos

Information from drug companies and opinion leaders

Related Concept Videos

Related Articles